Form 8-K - Current report:
SEC Accession No. 0001193125-24-181717
Filing Date
2024-07-19
Accepted
2024-07-19 17:04:54
Documents
15
Period of Report
2024-07-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d817873d8k.htm   iXBRL 8-K 28965
2 EX-1.1 d817873dex11.htm EX-1.1 195412
3 EX-5.1 d817873dex51.htm EX-5.1 6060
  Complete submission text file 0001193125-24-181717.txt   412263

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA slno-20240719.xsd EX-101.SCH 2851
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE slno-20240719_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slno-20240719_pre.xml EX-101.PRE 11262
18 EXTRACTED XBRL INSTANCE DOCUMENT d817873d8k_htm.xml XML 3672
Mailing Address 203 REDWOOD SHORES PARKWAY SUITE 500 REDWOOD CITY CA 94065
Business Address 203 REDWOOD SHORES PARKWAY SUITE 500 REDWOOD CITY CA 94065 650-213-8444
SOLENO THERAPEUTICS INC (Filer) CIK: 0001484565 (see all company filings)

EIN.: 770523891 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36593 | Film No.: 241128413
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)